300 related articles for article (PubMed ID: 17225940)
1. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
Rades D; Schulte R; Yekebas EF; Homann N; Schild SE; Dunst J
Strahlenther Onkol; 2007 Jan; 183(1):10-6. PubMed ID: 17225940
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
4. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
[TBL] [Abstract][Full Text] [Related]
7. Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.
Rades D; Schild SE; Yekebas EF; Job H; Schwarz R; Rudat V
Cancer; 2005 Jun; 103(11):2274-9. PubMed ID: 15852356
[TBL] [Abstract][Full Text] [Related]
8. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
Rades D; Golke H; Schild SE; Kilic E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):152-9. PubMed ID: 17967510
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
10. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
11. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL; Sargent DJ; Tepper JE; Wolmark N; O'Connell MJ; Begovic M; Allmer C; Colangelo L; Smalley SR; Haller DG; Martenson JA; Mayer RJ; Rich TA; Ajani JA; MacDonald JS; Willett CG; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1785-96. PubMed ID: 15067027
[TBL] [Abstract][Full Text] [Related]
12. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
Rades D; Kuhn H; Schultze J; Homann N; Brandenburg B; Schulte R; Krull A; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1087-93. PubMed ID: 17892921
[TBL] [Abstract][Full Text] [Related]
16. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
Rades D; Tribius S; Yekebas EF; Bahrehmand R; Wildfang I; Kilic E; Muellerleile U; Gross E; Schild SE; Alberti W
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):459-65. PubMed ID: 16584851
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.
Weiss C; Rödel F; Ott O; Engehausen DG; Papadopoulos T; Sauer R; Rödel C
Strahlenther Onkol; 2007 Oct; 183(10):552-6. PubMed ID: 17896086
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
19. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
Kelsey CR; Nelson JW; Willett CG; Chino JP; Clough RW; Bendell JC; Tyler DS; Hurwitz HI; Morse MA; Clary BM; Pappas TN; Czito BG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1436-41. PubMed ID: 17689032
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
